PubMed (11/28/17)

((“Urinary Bladder, Overactive”[Mesh] OR “Urinary Incontinence”[Mesh] OR “Enuresis”[Mesh] OR overactive bladder OR ((bladder or urine) AND incontinen*) OR enuresis OR nocturia OR “Nocturia”[Mesh] OR ((bladder or urine or urina*) and (overactive or incontinence or urgent or urgency or frequent or frequency or detrusor or leak*)) OR detrusor instability OR “Urinary Bladder, Neurogenic”[Mesh] OR (bladder AND (neurogen* or neurologic*)) OR “Urinary Incontinence, Urge”[Mesh] OR “Urinary Incontinence, Stress”[Mesh] OR ((urine OR urina* or bladder*) and urge*))

AND

(“Urinary Incontinence/Radiotherapy”[Mesh] OR “Urinary Incontinence/Rehabilitation”[Mesh] OR “Urinary Incontinence/Surgery”[Mesh] OR “Urinary Incontinence/Therapy”[Mesh] OR “Urinary Incontinence/Diet Therapy”[Mesh] OR “Urinary Incontinence/Nursing”[Mesh] OR “Urinary Incontinence/Drug”[Mesh] OR ((non pharmacologic* or nonpharmacologic*) AND “Treatment Outcome”[Mesh]) OR mirabegron OR “Adrenergic beta-3 Receptor Agonists”[Mesh] OR Resiniferatoxin OR “Botulinum Toxins”[Mesh] OR “Botulinum Toxins, Type A”[Mesh] OR botulinum OR botox OR estrogen* OR “Estrogens”[Mesh] OR Antimuscarinics OR oxybutynin chloride OR trospium chloride OR darifenacin OR solifenacin succinate OR fesoterodine OR tolterodine OR propiverine OR “Calcium Channel Blockers”[Mesh] OR Calcium Channel Blocker* OR nimodipine OR TRPV1 antagonists OR resiniferatoxin OR Tricyclic antidepressant* OR Tricyclic anti-depressant OR “Antidepressive Agents, Tricyclic”[Mesh] OR imipramine OR Beta 3 adeno-receptor agonists OR mirabegron OR “Neuromuscular Agents”[Mesh] OR neuromuscular agents OR ((pelvic floor or bladder) AND (train* or exercise or physical therapAy)) OR kegel OR “Physical Therapy Modalities”[Mesh] OR physiotherapy OR biofeedback OR “Biofeedback, Psychology”[Mesh] OR electric* stimulation OR “Electric Stimulation”[Mesh] OR nerve stimulation OR “Transcutaneous Electric Nerve Stimulation”[Mesh] OR stoller OR “Electrodes, Implanted”[Mesh] OR vesical pacing OR interstim OR “fluid therapy”[Mesh] OR (fluid AND (therapy or manage*)) OR urge suppression OR “Behavior Therapy”[Mesh] OR ((behavior* or behaviour*) AND (therapy or modif* or treat*)) OR “hypnosis”[Mesh] OR (hypnosis or hypnotherapy) OR “Drinking Behavior”[Mesh] OR “Complementary Therapies”[Mesh] OR ((alternative or complementary) AND (therapy or treatment)) OR “diet”[Mesh] OR diet OR dietary OR Vaginal cone* OR bladder support* OR (Urethra* AND (Plug or patch)) OR Pessar* OR Magnetic stimulation OR “Magnetic Field Therapy”[Mesh] OR Urethral bulking OR ((transurethral or periurethral) AND injection*) OR Posterior tibial nerve stimulation OR neuromodulation OR Coaptite OR (Vaginal AND (cone* OR weight*)) OR Impressa OR Macroplastique implants OR Milnacipran OR Savella OR Trospium OR Sanctura OR Onabotulinum toxin A OR Botox OR Paroxetine OR Paxil OR Mirabegron OR Myrbetriq OR solifenacin succinate OR vesicare OR Amitriptyline OR Elavil OR Rimabotulinum toxin B OR Myobloc OR Fluoxetine OR Prozac OR Duloxetine OR Cymbalta OR Citalopram OR Celexa OR Escitalopram OR Lexapro OR Levomilnacipran OR Fetzima OR AbobotulinumtoxinA OR Dysport OR oxybutynin chloride OR Ditropan OR Fluvoxamine OR Luvox CR OR Imipramine OR Tofranil OR Nortriptyline OR Pamelorl OR Clomipramine OR Anafranil OR IncobotulinumtoxinA OR Xeomin OR Doxepin OR Silenor OR Protriptyline OR Vivactil OR Trimipramine OR Surmontil OR 5-HT2 receptor antagonist OR Doxepin OR Silenor OR Sertraline OR Zoloft OR Tolterodine OR Detrol OR Desipramine OR Pertofrane OR Desipramine OR Norpramin OR Darifenacin OR Enablex OR Desvenlafaxine OR Pristiq OR Topical estrogen OR premarin OR synthetic conjugated estrogens)

AND

(“Cohort Studies”[Mesh] OR cohort OR “Clinical Trial” [Publication Type] OR “Clinical Trials as Topic”[Mesh] OR (follow-up or followup) OR longitudinal OR “Placebos”[Mesh] OR placebo* OR “Research Design”[Mesh] OR “Evaluation Studies” [Publication Type] OR “Evaluation Studies as Topic”[Mesh] OR “Comparative Study” [Publication Type] OR ((comparative or Intervention) AND study) OR Intervention Stud* OR pretest* OR pre test* OR posttest* OR post test* OR prepost* OR pre post* OR “before and after” OR interrupted time* OR time serie* OR intervention* OR ((“quasi-experiment*” OR quasiexperiment* OR quasi or experimental) and (method or study or trial or design*)) OR “Case-Control Studies”[Mesh] OR (case and control) OR “Random Allocation”[Mesh] OR “Double-Blind Method”[Mesh] OR “Single-Blind Method”[Mesh] OR random* OR “Clinical Trial” [Publication Type] OR “Clinical Trials as Topic”[Mesh] OR “Placebos”[Mesh] OR placebo OR ((clinical OR controlled) and trial*) OR ((singl* or doubl* or trebl* or tripl*) and (blind* or mask*)) OR rct OR crossover OR cross-over OR cross-over))

NOT

(“addresses”[pt] or “autobiography”[pt] or “bibliography”[pt] or “biography”[pt] or “case reports”[pt] or “congresses”[pt] or “dictionary”[pt] or “directory”[pt] or “editorial”[pt] or “festschrift”[pt] or “government publications”[pt] or “historical article”[pt] or “interview”[pt] or “lectures”[pt] or “legal cases”[pt] or “legislation”[pt] or “news”[pt] or “newspaper article”[pt] or “patient education handout”[pt] or “periodical index”[pt] or “comment on” or (“Animals”[Mesh] NOT “Humans”[Mesh]) OR rats[tw] or cow[tw] or cows[tw] or chicken*[tw] or horse[tw] or horses[tw] or mice[tw] or mouse[tw] or bovine[tw] or sheep or ovine or murinae or (“Men”[Mesh] NOT “Women”[Mesh]) OR “Pregnant Women”[Mesh])

Limits

2011-current

Cochrane (11/28/17)

((mh “Urinary Bladder, Overactive” OR mh “Urinary Incontinence” OR mh Enuresis OR overactive bladder OR ((bladder or urine) AND incontinen*) OR enuresis OR nocturia OR mh Nocturia OR ((bladder or urine) and (overactive or incontinence or urgent or urgency or frequent or frequency or detrusor or leak*)) OR detrusor instability OR mh “Urinary Bladder, Neurogenic” OR (bladder AND (neurogen* or neurologic*)) OR mh “Urinary Incontinence, Urge” OR mh “Urinary Incontinence, Stress” OR ((urine OR urina* or bladder*) and urge*)) NOT ((mh Men NOT mh Women) OR mh “Pregnant Women”))

AND

(mh “Urinary Incontinence/Radiotherapy” OR mh “Urinary Incontinence/Rehabilitation” OR mh “Urinary Incontinence/Surgery” OR mh “Urinary Incontinence/Therapy” OR mh “Urinary Incontinence/Diet Therapy” OR mh “Urinary Incontinence/Nursing” OR “Urinary Incontinence/Drug” OR ((non pharmacologic* or nonpharmacologic*) AND mh “Treatment Outcome”) OR mirabegron OR mh “Adrenergic beta-3 Receptor Agonists” OR Resiniferatoxin OR mh “Botulinum Toxins” OR mh “Botulinum Toxins, Type A” OR botulinum OR botox OR estrogen* OR mh Estrogens OR Antimuscarinics OR oxybutynin chloride OR trospium chloride OR darifenacin OR solifenacin succinate OR fesoterodine OR tolterodine OR propiverine OR mh “Calcium Channel Blockers” OR Calcium Channel Blocker* OR nimodipine OR TRPV1 antagonists OR resiniferatoxin OR Tricyclic antidepressant* OT Tricyclic anti-depressant OR mh “Antidepressive Agents, Tricyclic” OR imipramine OR Beta 3 adeno-receptor agonists OR mirabegron OR mh “Neuromuscular Agents” OR neuromuscular agents OR ((pelvic floor or bladder) AND (train* or exercise* or physical therap*)) OR kegel OR mh “Physical Therapy Modalities” OR physiotherapy OR biofeedback OR mh “Biofeedback, Psychology” OR electric* stimulation OR mh “Electric Stimulation" OR nerve stimulation OR mh “Transcutaneous Electric Nerve Stimulation" OR stoller OR mh “Electrodes, Implanted" OR (vesical pacing or interstim) OR mh “fluid therapy" OR (fluid AND (therapy or manage*)) OR urge suppression OR mh “Behavior Therapy” OR ((behavior* or behaviour*) AND (therapy or modif* or treat*)) OR mh hypnosis OR (hypnosis or hypnotherapy) OR mh “Drinking Behavior” OR mh “Complementary Therapies” OR ((alternative or complementary) AND (therapy or treatment)) OR mh diet OR diet OR mh “Quality of Life” OR biofeedback OR bladder support* OR impressa OR (Urethra* AND (Plug or patch)) OR Magnetic stimulation OR mh “Magnetic Field Therapy” OR Urethral bulking OR ((transurethral or periurethral) AND injection*) OR Pessar* OR Posterior tibial nerve stimulation OR neuromodulation OR Coaptite OR (Vaginal AND (cone* OR weight*)) OR Impressa OR Macroplastique implants OR Milnacipran OR Savella OR Trospium OR Sanctura OR Onabotulinum toxin A OR Botox OR Paroxetine OR Paxil OR Mirabegron OR Myrbetriq OR solifenacin succinate OR vesicare OR Amitriptyline OR Elavil OR Rimabotulinum toxin B OR Myobloc OR Fluoxetine OR Prozac OR Duloxetine OR Cymbalta OR Citalopram OR Celexa OR Escitalopram OR Lexapro OR Levomilnacipran OR Fetzima OR AbobotulinumtoxinA OR Dysport OR oxybutynin chloride OR Ditropan OR Fluvoxamine OR Luvox CR OR Imipramine OR Tofranil OR Nortriptyline OR Pamelorl OR Clomipramine OR Anafranil OR IncobotulinumtoxinA OR Xeomin OR Doxepin OR Silenor OR Protriptyline OR Vivactil OR Trimipramine OR Surmontil OR 5-HT2 receptor antagonist OR Doxepin OR Silenor OR Sertraline OR Zoloft OR Tolterodine OR Detrol OR Desipramine OR Pertofrane OR Desipramine OR Norpramin OR Darifenacin OR Enablex OR Desvenlafaxine OR Pristiq OR Topical estrogen OR premarin OR synthetic conjugated estrogens)

Limits

2011-

Embase (11/28/17)

urinary AND (‘incontinence’/exp OR incontinence) OR ‘enuresis’/exp OR enuresis OR overactive AND (‘bladder’/exp OR bladder) OR ‘nocturia’/exp OR nocturia AND nonpharmacological OR ‘non pharmacological’ OR ‘mirabegron’/exp OR mirabegron OR ‘beta 3 adrenergic receptor stimulating agent’/exp OR ‘beta 3 adrenergic receptor stimulating agent’ OR ‘resiniferatoxin’/exp OR ‘resiniferatoxin’ OR botulinum AND (‘toxins’/exp OR toxins) OR botox OR ‘estrogen’/exp OR ‘estrogen’ OR antimuscarinics OR ‘oxybutynin’ OR trospium AND chloride OR darifenacin OR fesoterodine OR tolterodine OR propiverine OR solifenacin AND succinate OR ‘calcium channel blocking agent’/exp OR ‘calcium channel blocking agent’ OR nimodipine OR trpv1 AND antagonists OR ‘resiniferatoxin’ OR ‘antidepressant agent’ OR imipramine OR ‘muscle relaxant agent’ OR ‘physiotherapy’/exp OR physiotherapy OR ‘biofeedback’/exp OR biofeedback OR electric AND (‘stimulation’/exp OR stimulation) OR ‘nerve’/de AND ‘stimulation’/de OR ‘fluid therapy’ OR urge AND suppression OR ‘behavior therapy’ OR ‘behavior therapy’/de OR ‘hypnosis’/exp OR ‘hypnosis’ OR ‘alternative medicine’/exp OR ‘alternative medicine’ OR ‘diet’/exp OR ‘diet’ OR vaginal AND cone OR ‘magnetic stimulation’/de OR ‘magnetic stimulation’ OR urethral AND bulking OR ‘vagina pessary’ OR impressa OR milnacipran OR savella OR trospium OR sanctura OR paroxetine OR paxil OR mirabegron OR myrbetriq OR ‘solifenacin succinate’ OR vesicare OR amitriptyline OR elavil OR ‘rimabotulinum toxin b’ OR myobloc OR fluoxetine OR prozac OR duloxetine OR cymbalta OR citalopram OR celexa OR escitalopram OR lexapro OR levomilnacipran OR fetzima OR abobotulinumtoxina OR dysport OR oxybutynin AND chloride OR ditropan OR fluvoxamine OR luvox OR imipramine OR tofranil OR nortriptyline OR pamelorl OR clomipramine OR anafranil OR incobotulinumtoxina OR xeomin OR protriptyline OR vivactil OR trimipramine OR surmontil OR doxepin OR silenor OR sertraline OR zoloft OR tolterodine OR detrol OR pertofrane OR desipramine OR norpramin OR darifenacin OR enablex OR desvenlafaxine OR pristiq OR premarin AND ‘cohort analysis’ OR ‘controlled clinical trial’/exp OR ‘controlled clinical trial’ OR ‘evaluation study’ OR ‘comparative study’ OR ‘intervention study’ OR ‘case control study’ OR ‘randomized controlled trial’ OR ‘crossover procedure’ AND ([article]/lim OR [article in press]/lim OR [conference abstract]/lim OR [conference paper]/lim) AND [female]/lim AND [humans]/lim AND [2011–2017]/py

CINAHL/PsycINFO (11/28/17)

((“Urinary Bladder, Overactive” OR mh “Urinary Incontinence” OR mh Enuresis OR overactive bladder OR ((bladder or urine) AND incontinen*) OR enuresis OR nocturia OR mh Nocturia OR ((bladder or urine) and (overactive or incontinence or urgent or urgency or frequent or frequency or detrusor or leak*)) OR detrusor instability OR mh “Urinary Bladder, Neurogenic” OR (bladder AND (neurogen* or neurologic*)) OR mh “Urinary Incontinence, Urge” OR mh “Urinary Incontinence, Stress” OR ((urine OR urina* or bladder*) and urge*)) NOT ((mh Men NOT mh Women) OR mh “Pregnant Women”))

AND

(mirabegron OR Resiniferatoxin OR “Botulinum Toxins” OR botulinum OR botox OR estrogen* OR Antimuscarinics OR oxybutynin chloride OR trospium chloride OR darifenacin OR solifenacin succinate OR fesoterodine OR tolterodine OR propiverine OR Calcium Channel Blocker* OR nimodipine OR TRPV1 antagonists OR resiniferatoxin OR Tricyclic antidepressants OR imipramine OR Beta 3 adeno-receptor agonists OR mirabegron OR “Neuromuscular Agents” OR neuromuscular agents OR ((pelvic floor or bladder) AND (train* or exercise or physical therapy)) OR kegel OR “Physical Therapy” OR physiotherapy OR biofeedback OR electric* stimulation OR nerve stimulation OR “Transcutaneous Electric Nerve Stimulation" OR stoller OR vesical pacing OR interstim OR (fluid AND (therapy or manage*)) OR urge suppression OR ((behavior* or behaviour*) AND (therapy or modif* or treat*)) OR hypnosis OR hypnotherapy) OR “Drinking Behavior” OR ((alternative or complementary) AND (therapy or treatment)) OR diet OR “Quality of Life” OR biofeedback OR Vaginal cone* OR bladder support* OR impressa OR (Urethra* AND (Plug OR patch)) OR Magnetic stimulation OR Magnetic Field Therapy OR Urethral bulking OR ((transurethral or periurethral) AND injection*) OR Intravaginal electrical stimulation OR Magnetic stimulation OR Pessar* OR Posterior tibial nerve stimulation OR neuromodulation OR Coaptite OR Macroplastique implants OR Milnacipran OR Savella OR Trospium OR Sanctura OR Paroxetine OR Paxil OR Mirabegron OR Myrbetriq OR solifenacin succinate OR vesicare OR Amitriptyline OR Elavil OR Rimabotulinum toxin B OR Myobloc OR Fluoxetine OR Prozac OR Duloxetine OR Cymbalta OR Citalopram OR Celexa OR Escitalopram OR Lexapro OR Levomilnacipran OR Fetzima OR AbobotulinumtoxinA OR Dysport OR oxybutynin chloride OR Ditropan OR Fluvoxamine OR Luvox CR OR Imipramine OR Tofranil OR Nortriptyline OR Pamelorl OR Clomipramine OR Anafranil OR IncobotulinumtoxinA OR Xeomin OR Doxepin OR Silenor OR Protriptyline OR Vivactil OR Trimipramine OR Surmontil OR Doxepin OR Silenor OR Sertraline OR Zoloft OR Tolterodine OR Detrol OR Desipramine OR Pertofrane OR Desipramine OR Norpramin OR Darifenacin OR Enablex OR Desvenlafaxine OR Pristiq OR Topical estrogen OR premarin OR synthetic conjugated estrogens)

ClinicalTrials.gov (6/13/17)

urinary incontinence OR overactive bladder OR enuresis OR nocturia OR detrusor instability

• limit to adult and senior
• limit to studies with female participants
• limit first received date to 1/1/2011 to 12/31/2017